27 August 2021 - Pharmaceutical Research and Manufacturers of America president and CEO Stephen J. Ubl made the following statement after the nonpartisan Congressional Budget Office released a new report that found policies like those included in Speaker Nancy Pelosi's drug pricing plan will lead to 60 fewer new treatments in the next three decades.

The report finds that even under the Congressional Budget Office 's conservative assumptions at least 60 new treatments and cures will be sacrificed if this proposal becomes reality and is further proof that patients with devastating disease could be denied access to medicines today and in the future.

Read Pharmaceutical Research and Manufacturers of America press release